Company news

Edwards Lifesciences Corporation news in 2026

Edwards Lifesciences Corporation's news releases, calls and decks from 2026, newest first.

View company

Edwards Lifesciences Reports Third Quarter Results

November 4, 2026

CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System

November 2, 2026

Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features

November 2, 2026

FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease

October 21, 2026

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

October 7, 2026

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

October 5, 2026

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

October 1, 2026

Edwards Lifesciences Comments on TAVR National Coverage Decision

September 10, 2026

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

September 2, 2026

Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care

August 19, 2026

Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

July 16, 2026

Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

June 26, 2026

Edwards Lifesciences Announces Appointment of CFO

May 4, 2026

Ten-year pivotal data reinforce the long-term durability of Edwards' RESILIA tissue

May 4, 2026

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

May 2, 2026

Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference

April 28, 2026

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

April 16, 2026

Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits

March 30, 2026

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

February 26, 2026

New survey by Edwards Lifesciences uncovers just how much Americans know about their heart health

February 24, 2026

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

February 19, 2026

Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day

February 13, 2026

Edwards Lifesciences Reports Fourth Quarter Results

February 10, 2026

Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

February 3, 2026

Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

February 2, 2026

Edwards Comments on JenaValve Acquisition

January 9, 2026

Calls in 2026

Decks in 2026